ID PA1B3_BOVIN Reviewed; 232 AA. AC Q29460; Q0VCF0; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 27-MAR-2024, entry version 155. DE RecName: Full=Platelet-activating factor acetylhydrolase IB subunit alpha1 {ECO:0000305}; DE EC=3.1.1.47 {ECO:0000269|PubMed:10542206}; DE AltName: Full=PAF acetylhydrolase 29 kDa subunit; DE Short=PAF-AH 29 kDa subunit; DE AltName: Full=PAF-AH subunit gamma; DE Short=PAFAH subunit gamma; GN Name=PAFAH1B3 {ECO:0000250|UniProtKB:Q15102}; Synonyms=PAFAHG; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 38-85; 96-111 AND RP 119-151. RC TISSUE=Brain; RX PubMed=8083218; DOI=10.1016/s0021-9258(17)31632-0; RA Hattori M., Adachi H., Tsujimoto M., Arai H., Inoue K.; RT "The catalytic subunit of bovine brain platelet-activating factor RT acetylhydrolase is a novel type of serine esterase."; RL J. Biol. Chem. 269:23150-23155(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Hereford; TISSUE=Fetal brain; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases. RN [3] RP SUBUNIT, CATALYTIC ACTIVITY, FUNCTION, ACTIVITY REGULATION, AND INTERACTION RP WITH PAFAH1B1. RX PubMed=10542206; DOI=10.1074/jbc.274.45.31827; RA Manya H., Aoki J., Kato H., Ishii J., Hino S., Arai H., Inoue K.; RT "Biochemical characterization of various catalytic complexes of the brain RT platelet-activating factor acetylhydrolase."; RL J. Biol. Chem. 274:31827-31832(1999). RN [4] RP X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS), AND ACTIVE SITE. RX PubMed=8985254; DOI=10.1038/385089a0; RA Ho Y.S., Swenson L., Derewenda U., Serre L., Wei Y., Dauter Z., Hattori M., RA Adachi T., Aoki J., Arai H., Inoue K., Derewenda Z.S.; RT "Brain acetylhydrolase that inactivates platelet-activating factor is a G- RT protein-like trimer."; RL Nature 385:89-93(1997). CC -!- FUNCTION: Alpha1 catalytic subunit of the cytosolic type I platelet- CC activating factor (PAF) acetylhydrolase (PAF-AH (I)) heterotetrameric CC enzyme that catalyzes the hydrolyze of the acetyl group at the sn-2 CC position of PAF and its analogs and modulates the action of PAF CC (PubMed:10542206). The activity and substrate specificity of PAF-AH (I) CC are affected by its subunit composition (PubMed:10542206). Both CC alpha1/alpha1 homodimer (PAFAH1B3/PAFAH1B3 homodimer) and alpha1/alpha2 CC heterodimer(PAFAH1B3/PAFAH1B2 heterodimer) hydrolyze 1-O-alkyl-2- CC acetyl-sn-glycero-3-phosphoric acid (AAGPA) more efficiently than PAF, CC but they have little hydrolytic activity towards 1-O-alkyl-2-acetyl-sn- CC glycero-3-phosphorylethanolamine (AAGPE) (PubMed:10542206). Plays an CC important role during the development of brain. CC {ECO:0000269|PubMed:10542206}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-O- CC alkyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:17777, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:30909, ChEBI:CHEBI:36707; EC=3.1.1.47; CC Evidence={ECO:0000269|PubMed:10542206}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17778; CC Evidence={ECO:0000305|PubMed:10542206}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1- CC O-hexadecyl-sn-glycero-3-phosphocholine + acetate + H(+); CC Xref=Rhea:RHEA:40479, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:44811, ChEBI:CHEBI:64496; CC Evidence={ECO:0000269|PubMed:10542206}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40480; CC Evidence={ECO:0000305|PubMed:10542206}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphate + H2O = 1-O- CC hexadecyl-sn-glycero-3-phosphate + acetate + H(+); CC Xref=Rhea:RHEA:41704, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30089, ChEBI:CHEBI:77580, ChEBI:CHEBI:78385; CC Evidence={ECO:0000269|PubMed:10542206}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41705; CC Evidence={ECO:0000305|PubMed:10542206}; CC -!- ACTIVITY REGULATION: Beta subunit (PAFAH1B1) inhibits the CC acetylhydrolase activity of the alpha1/alpha1 catalytic homodimer. CC {ECO:0000269|PubMed:10542206}. CC -!- SUBUNIT: Forms a catalytic dimer which is either homodimer CC (alpha1/alpha1 homodimer) or heterodimer with PAFAH1B2 (alpha1/alpha2 CC heterodimer) (PubMed:10542206). Component of the cytosolic (PAF-AH (I)) CC heterotetrameric enzyme, which is composed of PAFAH1B1 (beta), PAFAH1B2 CC (alpha2) and PAFAH1B3 (alpha1) subunits (PubMed:10542206). The CC catalytic activity of the enzyme resides in the alpha1 (PAFAH1B3) and CC alpha2 (PAFAH1B2) subunits, whereas the beta subunit (PAFAH1B1) has CC regulatory activity (PubMed:10542206). Trimer formation is not CC essential for the catalytic activity (PubMed:10542206). Interacts with CC VLDLR; this interaction may modulate the Reelin pathway (By CC similarity). {ECO:0000250|UniProtKB:Q61205, CC ECO:0000269|PubMed:10542206}. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- MISCELLANEOUS: Originally the subunits of the type I platelet- CC activating factor (PAF) acetylhydrolase was named alpha (PAFAH1B1), CC beta (PAFAH1B2) and gamma (PAFAH1B3) (By similarity). Now these CC subunits have been renamed beta (PAFAH1B1), alpha2 (PAFAH1B2) and CC alpha1 (PAFAH1B3) respectively (PubMed:8985254). CC {ECO:0000250|UniProtKB:P43034, ECO:0000250|UniProtKB:P68402, CC ECO:0000250|UniProtKB:Q15102, ECO:0000269|PubMed:8985254}. CC -!- SIMILARITY: Belongs to the 'GDSL' lipolytic enzyme family. Platelet- CC activating factor acetylhydrolase IB beta/gamma subunits subfamily. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D30789; BAA06455.1; -; mRNA. DR EMBL; BC120202; AAI20203.1; -; mRNA. DR PIR; A54754; A54754. DR RefSeq; NP_777090.1; NM_174665.2. DR PDB; 1BWP; X-ray; 2.10 A; A=1-232. DR PDB; 1BWQ; X-ray; 2.30 A; A=1-232. DR PDB; 1BWR; X-ray; 2.40 A; A=1-232. DR PDB; 1ES9; X-ray; 1.30 A; A=1-232. DR PDB; 1FXW; X-ray; 2.10 A; A=1-232. DR PDB; 1WAB; X-ray; 1.70 A; A=1-232. DR PDB; 3DT6; X-ray; 2.10 A; A=1-232. DR PDB; 3DT8; X-ray; 1.85 A; A=1-232. DR PDB; 3DT9; X-ray; 1.85 A; A=1-232. DR PDBsum; 1BWP; -. DR PDBsum; 1BWQ; -. DR PDBsum; 1BWR; -. DR PDBsum; 1ES9; -. DR PDBsum; 1FXW; -. DR PDBsum; 1WAB; -. DR PDBsum; 3DT6; -. DR PDBsum; 3DT8; -. DR PDBsum; 3DT9; -. DR AlphaFoldDB; Q29460; -. DR SMR; Q29460; -. DR CORUM; Q29460; -. DR IntAct; Q29460; 1. DR MINT; Q29460; -. DR STRING; 9913.ENSBTAP00000066532; -. DR SwissLipids; SLP:000000693; -. DR iPTMnet; Q29460; -. DR PaxDb; 9913-ENSBTAP00000026366; -. DR PeptideAtlas; Q29460; -. DR Ensembl; ENSBTAT00000026366.4; ENSBTAP00000026366.3; ENSBTAG00000019787.4. DR Ensembl; ENSBTAT00000067093.1; ENSBTAP00000066532.1; ENSBTAG00000019787.4. DR GeneID; 282515; -. DR KEGG; bta:282515; -. DR CTD; 5050; -. DR VEuPathDB; HostDB:ENSBTAG00000019787; -. DR VGNC; VGNC:32551; PAFAH1B3. DR eggNOG; KOG1388; Eukaryota. DR GeneTree; ENSGT00950000183199; -. DR HOGENOM; CLU_051989_2_0_1; -. DR InParanoid; Q29460; -. DR OMA; HHRFIAD; -. DR OrthoDB; 4162633at2759; -. DR TreeFam; TF323955; -. DR BRENDA; 3.1.1.47; 908. DR Reactome; R-BTA-6811436; COPI-independent Golgi-to-ER retrograde traffic. DR EvolutionaryTrace; Q29460; -. DR Proteomes; UP000009136; Chromosome 18. DR Bgee; ENSBTAG00000019787; Expressed in pons and 106 other cell types or tissues. DR GO; GO:0008247; C:1-alkyl-2-acetylglycerophosphocholine esterase complex; IDA:UniProtKB. DR GO; GO:0005737; C:cytoplasm; ISS:AgBase. DR GO; GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IDA:UniProtKB. DR GO; GO:0047179; F:platelet-activating factor acetyltransferase activity; IBA:GO_Central. DR GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB. DR GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW. DR GO; GO:0007283; P:spermatogenesis; ISS:AgBase. DR CDD; cd01820; PAF_acetylesterase_like; 1. DR Gene3D; 3.40.50.1110; SGNH hydrolase; 1. DR InterPro; IPR013830; SGNH_hydro. DR InterPro; IPR036514; SGNH_hydro_sf. DR PANTHER; PTHR11852; PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE; 1. DR PANTHER; PTHR11852:SF2; PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA1; 1. DR Pfam; PF13472; Lipase_GDSL_2; 1. DR SUPFAM; SSF52266; SGNH hydrolase; 1. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; Hydrolase; KW Lipid degradation; Lipid metabolism; Phosphoprotein; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:Q15102" FT CHAIN 2..232 FT /note="Platelet-activating factor acetylhydrolase IB FT subunit alpha1" FT /id="PRO_0000058154" FT ACT_SITE 47 FT /evidence="ECO:0000269|PubMed:8985254, FT ECO:0007744|PDB:1BWP" FT ACT_SITE 192 FT /evidence="ECO:0000269|PubMed:8985254, FT ECO:0007744|PDB:1BWP" FT ACT_SITE 195 FT /evidence="ECO:0000269|PubMed:8985254, FT ECO:0007744|PDB:1BWP" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0000250|UniProtKB:Q15102" FT MOD_RES 2 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q15102" FT CONFLICT 79 FT /note="Missing (in Ref. 1; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 150 FT /note="E -> L (in Ref. 1; AA sequence)" FT /evidence="ECO:0000305" FT HELIX 7..9 FT /evidence="ECO:0007829|PDB:1ES9" FT STRAND 17..20 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 22..36 FT /evidence="ECO:0007829|PDB:1ES9" FT STRAND 40..46 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 47..50 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 52..55 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 58..61 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 63..65 FT /evidence="ECO:0007829|PDB:1ES9" FT STRAND 67..71 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 77..85 FT /evidence="ECO:0007829|PDB:1ES9" FT TURN 86..91 FT /evidence="ECO:0007829|PDB:1ES9" FT STRAND 95..100 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 110..127 FT /evidence="ECO:0007829|PDB:1ES9" FT STRAND 132..136 FT /evidence="ECO:0007829|PDB:1ES9" FT STRAND 142..144 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 147..164 FT /evidence="ECO:0007829|PDB:1ES9" FT STRAND 169..172 FT /evidence="ECO:0007829|PDB:1ES9" FT TURN 187..189 FT /evidence="ECO:0007829|PDB:1ES9" FT STRAND 193..196 FT /evidence="ECO:0007829|PDB:1ES9" FT HELIX 198..215 FT /evidence="ECO:0007829|PDB:1ES9" SQ SEQUENCE 232 AA; 25865 MW; 81C2CECA8E2204ED CRC64; MSGDENPASK PTPVQDVQGD GRWMSLHHRF VADSKDKEPE VVFIGDSLVQ LMHQCEIWRE LFSPLHALNF GIGGDSTQHV LWRLENGELE HIRPKIVVVW VGTNNHGHTA EQVTGGIKAI VQLVNERQPQ ARVVVLGLLP RGQHPNPLRE KNRRVNELVR AALAGHPRAH FLDADPGFVH SDGTISHHDM YDYLHLSRLG YTPVCRALHS LLLRLLTQDQ GQGGAPLPEP SP //